Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of different induction agents
(alemtuzumab, basiliximab or rabbit anti-thymocyte globulin) in renal transplant recipients
treated with tacrolimus, mycophenolate mofetil (MMF) and a rapid steroid withdrawal.